Continuing the Conversation: Optimizing the Role of the Pharmacist in Diabetes Management with CGM

Continuing the Conversation: Optimizing the Role of the Pharmacist in Diabetes Management with CGM

On-Demand Accredited Online Article

Faculty

Amanda M. Stahnke, PharmD, BCACP
Clinical Associate Professor
University of Missouri-Kansas City School of Pharmacy
Department of Pharmacy Practice and Administration

Patient-Aligned Care Team Pharmacist
Kansas City Veterans Affairs Medical Center
Kansas City, Missouri

Kathryn M. Holt, PharmD, BCPS
Clinical Assistant Professor
University of Missouri-Kansas City School of Pharmacy
Department of Pharmacy Practice & Administration

Clinical Pharmacy Specialist
Ambulatory Care
Meritas Health North Kansas City
Kansas City, Missouri
 
Program Description
There are many challenges and limitations to traditional methods of monitoring glycemic control among patients with both type 1 and type 2 diabetes. However, continuous glucose monitoring (CGM) devices can provide both patients and clinicians with comprehensive data on glucose fluctuations throughout the day. A variety of CGM products are on the market, each with associated clinical benefits, and it is important that pharmacists recognize the nuances of each product. Community pharmacists are ideally positioned to provide education to health care providers and patients on the concept of CGM and its potential to improve and individualize diabetes management. Especially during the COVID-19 pandemic, the use of CGM has been beneficial in the remote monitoring of patients with diabetes. As the use of remote monitoring with CGM devices becomes the new standard of care in diabetes management, pharmacists will have important roles in assisting patients in the setup of their device and explaining how to interpret data reports. This activity will also review potential access barriers for patients, with strategies pharmacists can use to address issues related to cost, coverage of associated supplies, and use of device mechanics.

Target Audience: Retail pharmacists
Type of Activity: Application
Release date: May 27, 2021
Expiration date: June 15, 2022
Time to complete activity: 2.0 hours
Fee: Free

Educational Objectives
At the completion of this activity, participants will be able to:

• Classify the limitations of self-monitoring of blood glucose and the evolving role of continuous glucose monitoring (CGM) devices in the management of diabetes
• Examine the FDA-approved CGM devices including features, proper use, and accuracy
• Determine the clinical benefits associated with CGM devices and impact that data have on diabetes management
• Identify the role of the pharmacist in recognizing patients who may benefit from CGM devices and providing necessary counseling to improve diabetes management

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEU) under the ACPE universal activity number 0290-0000-21-232-H01-P. The activity is available for CE credit through June 15, 2022.


Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, read the article in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

---

Disclosures

Amanda M. Stahnke, PharmD, BCACP, and Kathryn M. Holt, PharmD, BCPS, have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Rose Namissa, PharmD, BCPS; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms